Orchid Pharma Limited (ORCHPHARMA.NS) NSE

721.00

+19(+2.71%)

Updated at October 01 02:33PM

Currency In INR

Valuation

Market Cap39.71B
Enterprise Value41.24B
P/E Ratio42.91
PEG Ratio-2.96
Price/Sales Ratio4.3
Price/Book Ratio2.89
Enterprise/Revenue4.48
Enterprise/EBITDA29.26

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.1
Operating Margin0.19

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue9.22B
Revenue/Share167.69
Gross Profit3.78B
EBITDA1.45B
Net Income996.57M
Diluted EPS19.65

Balance Sheet

Total Cash1.83B
Total Cash/Share36.02
Total Debt1.75B
Total Debt/Equity0.14
Current Ratio2.83
Book Value Per Share249.88

Price History

52-Week Change-45.98
52-Week High1,997.4
52-Week Low603.8
Moving Average 50 Days741.45
Moving Average 200 Days928.53

Statistics

Average Volume97,324
Shares Outstanding50.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:218
Last Split DateJuly 25, 2019